Methods and systems are provided for anesthetic agent leakage diagnostics. In one embodiment, a method for diagnosing leaks in an anesthetic vaporizer includes calculating a leakage rate based on measurements of an anesthetic agent level in a sump of the anesthetic vaporizer, the measurements received from a fluid level sensor at a first time and a second time, and outputting a maintenance alert responsive to the leakage rate exceeding a threshold.

A tank for accumulating oxygen enriched air from an oxygen concentration device is disclosed. The oxygen concentration device includes a canister including a nitrogen-adsorbent material. A compressor is coupled to the canister. The compressor compresses air for the canister to produce oxygen enriched air in a swing adsorption process. The tank includes a closed container for collecting oxygen enriched air produced in the canister. An inlet is coupled to the container. An outlet in the container allows a patient to inhale the collected oxygen enriched air. An adsorbent material within the container adsorbs oxygen enriched air added to the tank from the canister.

The present invention relates to a device for measuring, recording, and acting in response to changes in air pressures encountered through the lumen of a connected needle. The device signals when it has been powered and signals when the device recognizes both pressures and pressure change rates indicative of synovial cavity joint penetration, such as knee joint penetration. Synovial cavity pressures detected and acted upon may either be supra- (positive) or sub-atmospheric (negative). Internal light emitting diodes and a laptop connected display are demonstrated as signaling and communication mechanisms. Methods for delivering medicaments into human and animal intra-articular cavities or joints such as synovial cavities are provided. Furthermore, methods for facilitating the diagnoses of joint effusion also are provided.

A dialysis machine (e.g., a peritoneal dialysis (PD) machine) can include a pressure sensor mounted at a proximal end of a patient line made of a distensible material that provides PD solution to a patient through a catheter. During treatment, an occlusion can occur at different locations in the patient line and/or the catheter. When an incremental volume of additional solution is provided to the patient line while the occlusion is present, a change in pressure results. The change in pressure depends on the dimensions and the distensibility of the non-occluded portion of the patient line. If the change in pressure, the incremental volume, the properties related to the distensibility of the patient line, and some of the dimensions of the patient line are known, the location of the occlusion can be inferred. The occlusion type can be inferred based on the determined location.

An infusion pump system is disclosed. The infusion pump system includes an infusion pump and a controller device in wireless communication with the infusion pump, wherein the controller including instructions for controlling the infusion pump, wherein the instructions may be synchronized with a secure web portal.

An infusion pump system providing therapy to a patient in a closed-loop or semi-closed loop mode can safely automatically revert to open-loop therapy. The system stores a default open-loop basal rate profile in memory. The system also continually tracks the insulin on board for the patient over a plurality of closed-loop therapy intervals. When an error or event occurs requiring reversion to open-loop therapy, the system automatically provides therapy according to the open-loop basal rate profile and the tracked insulin on board amount.

A sensor assembly for an injection device may include a housing and/or a mechanical interface. The housing may include a sensor and/or a wireless communication device. The sensor may be configured to detect a movement of a component of the injection device associated with an injection operation of the injection device. The wireless communication device may be configured to communicate, to a computing device, information associated with the movement of the component of the injection device. The mechanical interface may be configured to attach the housing to an exterior surface of the injection device. A system may include the sensor assembly and the injection device.

A ventilation device for artificial ventilation, having: —a ventilation gas source; —a ventilation conducting assembly for conducting inspiratory ventilation gas from the ventilation gas source to a patient-side, proximal ventilation-gas outlet opening and for conducting expiratory ventilation gas away from a proximal ventilation-gas inlet opening; —a pressure-changing assembly for changing the pressure of the ventilation gas flowing in the ventilation conducting assembly; —a control device, which is designed to control the operation of the ventilation gas source and/or the operation of the pressure-changing assembly; —an evaluation device for processing sensor signals; and —an O2 sensor assembly for determining an O2 concentration value representing the oxygen concentration of the ventilation gas flowing in the ventilation conducting assembly, wherein the O2 sensor assembly outputs O2 sensor signals, which contain information regarding the O2 concentration value, to the evaluation device, and wherein the evaluation device is designed to determine, on the basis of the O2 sensor signals, an O2 change value representing a change in the O2 concentration value and, if the O2 change value satisfies a predefined condition, to infer degradation of the O2 sensor assembly and to output a signal.

Methods and systems are provided for assisting a user of a wearable biosignal monitoring device (2) in adjusting the device to achieve optimum fit and positioning. The biosignal monitoring devices considered use integrated bio sensors (5) to monitor the user’s physiological activity for various purposes such as tracking daily activity patterns, determining mood, and monitoring sleep stages, among others. It is determined either during device setup or during primary use of the device whether the current fit and positioning of the device (2) enable the bio sensors (5) to properly sense the physiological signals needed for the device to perform its primary function. The user is then informed either after initial device setup whether adjustments need to be made in order to optimize device function during primary use, or is informed after primary use whether adjustments need to be made in order to improve device function during future primary use.

A renal failure therapy system having an electrically floating fluid pathway is disclosed. The example system includes a dialyzer, a blood circuit in fluid communication with the dialyzer, and a dialysis fluid circuit in fluid communication with the dialyzer. The system also includes an electrically floating fluid pathway comprising at least a portion of the blood circuit and at least a portion of the dialysis fluid circuit. The only electrical path to ground is via used dialysis fluid traveling through the renal failure therapy system to earth ground. The disclosed system enables at least one electrical component in the at least a portion of the dialysis fluid circuit of the electrically floating fluid pathway to be electrically bypassed.